Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT04227509 · COMPLETED
Trial details
- NCT number
- NCT04227509
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2024-08-21
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.